Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma

被引：9
|
作者：
Martinez-Trufero, Javier [1 ]
Alfaro, Jorge [2 ]
Felipo, Francesc [2 ]
Alvarez, Maria [1 ]
Madani, Julia [1 ]
Cebollero, Ana [1 ]
机构：
[1] Hosp Univ Miguel Servet, Dept Med Oncol, Zaragoza 50009, Spain
[2] Hosp Univ Miguel Servet, Dept Pathol, Zaragoza 50009, Spain
来源：
ANTI-CANCER DRUGS | 2010年 / 21卷 / 08期
关键词：
hemangiopericytoma; rare tumor; solitary fibrous tumor; trabectedin; SOFT-TISSUE SARCOMA; CENTRAL-NERVOUS-SYSTEM; MALIGNANT HEMANGIOPERICYTOMA; PHASE-II; FIBROUS TUMOR; ECTEINASCIDIN-743; CHEMOTHERAPY; RADIOTHERAPY; EXPERIENCE; SUNITINIB;
D O I：
10.1097/CAD.0b013e32833d19f0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Meningeal hemangiopericytoma is an uncommon and aggressive malignancy that, in contrast to meningiomas, shows a high propensity for local recurrence and the development of late extraneural metastases. The results of chemotherapy in advanced hemangiopericytoma have been disappointing, and they have been particularly poor in cases located in the meninges. We report a case of a heavily pretreated metastatic meningeal hemangiopericytoma in which fourth-line chemotherapy with trabectedin, a marine-derived antineoplastic agent effective in treating advanced soft tissue sarcomas, resulted in clinical benefit. Anti-Cancer Drugs 21: 795-798 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码：795 / 798
页数：4
相关论文
共 50 条
  • [21] Comparison of Response Evaluation Criteria in Solid Tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: A retrospective analysis
    Taieb, Sophie
    Saada-Bouzid, Esma
    Tresch, Emmanuelle
    Ryckewaert, Thomas
    Bompas, Emmanuelle
    Italiano, Antoine
    Guillemet, Cecile
    Peugniez, Charlotte
    Piperno-Neumann, Sophie
    Thyss, Antoine
    Maynou, Carlos
    Clisant, Stephanie
    Penel, Nicolas
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (02) : 202 - 209
  • [22] Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic options
    Duffaud, Florence
    Maki, Robert G.
    Jones, Robin L.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (04) : 501 - 512
  • [23] Trabectedin for the Treatment of Advanced Metastatic Soft Tissue Sarcoma: A NICE Single Technology Appraisal
    Rafia, Rachid
    Simpson, Emma
    Stevenson, Matt
    Papaioannou, Diana
    PHARMACOECONOMICS, 2013, 31 (06) : 471 - 478
  • [24] Long lasting response of trabectedin in patient with gastric leiomyosarcoma with liver metastasis: an update to previous report
    Rastogi, Sameer
    Kalra, Kaushal
    Manasa, Parisa
    Rajawat, Monali
    Mehta, Varshil
    FUTURE SCIENCE OA, 2020, 6 (01):
  • [25] A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin
    Moura, David S.
    Pena-Chilet, Maria
    Cordero Varela, Juan Antonio
    Alvarez-Alegret, Ramiro
    Agra-Pujol, Carolina
    Izquierdo, Francisco
    Ramos, Rafael
    Ortega-Medina, Luis
    Martin-Davila, Francisco
    Castilla-Ramirez, Carolina
    Nieves Hernandez-Leon, Carmen
    Romagosa, Cleofe
    Vaz Salgado, Maria Angeles
    Lavernia, Javier
    Bague, Silvia
    Mayodormo-Aranda, Empar
    Vicioso, Luis
    Hernandez Barcelo, Jose Emilio
    Rubio-Casadevall, Jordi
    de Juan, Ana
    Fiano-Valverde, Maria Concepcion
    Hindi, Nadia
    Lopez-Alvarez, Maria
    Lacerenza, Serena
    Dopazo, Joaquin
    Gutierrez, Antonio
    Alvarez, Rosa
    Valverde, Claudia
    Martinez-Trufero, Javier
    Martin-Broto, Javier
    MOLECULAR ONCOLOGY, 2021, 15 (12) : 3691 - 3705
  • [26] Long-Term Response after 94 Cycles of Trabectedin in a Patient with Metastatic Leiomyosarcoma of the Lower Extremity
    Cordeiro, Magda
    Casanova, Jose Manuel
    Rodrigues, Joana
    Freitas, Joao
    Fonseca, Ruben
    de Oliveira, Rui Caetano
    Tavares, Paulo Freitas
    CASE REPORTS IN ONCOLOGY, 2020, 13 (01): : 113 - 119
  • [27] Successful treatment of a huge meningeal hemangiopericytoma using preoperative autologous transfusion and hemodilutional autologous transfusion: Case report
    Asano, K
    Ohkuma, H
    Kudo, K
    Takemura, A
    Suzuki, S
    Kubo, O
    NEUROLOGICAL SURGERY, 2002, 30 (06): : 631 - 637
  • [28] DURABLE RESPONSE WITH ORAL PPARΓ AGONIST EFATUTAZONE (CS-7017) IN A PRETREATED PATIENT WITH ADVANCED THYMIC CARCINOMA
    Murakami, Haruyasu
    Ono, Akira
    Shukuya, Takehito
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S422 - S422
  • [29] Meningeal "Lazarus Response" to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib
    Facchinetti, Francesco
    Levy, Antonin
    Ammari, Samy
    Naltet, Charles
    Lavaud, Pernelle
    Aldea, Mihaela
    Vasseur, Damien
    Planchard, David
    Besse, Benjamin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2805 - 2810
  • [30] Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma
    Lamm, W.
    Amann, G.
    Brodowicz, T.
    CASE REPORTS IN ONCOLOGY, 2010, 3 (03): : 477 - 479
12345